LINC01134 and cancer: LINC01134 and MKLN1-AS were found to promote HCC progression or metastasis by previous studies [24–28], suggesting that the two lncRNAs might be more specific in HCC, while NRAV and CMB9-22P13.1 were rarely reported as an oncogene in cancers.